UK Sovereign AI Fund invests in Cambridge AI startup CuspAI
United KingdomNews
The UK’s Sovereign AI Fund, backed by Jeff Bezos, co-led a $450m Series B round for Cambridge-based AI startup CuspAI. The investment values CuspAI at $2.6bn, five times its valuation from September 2025. CuspAI develops AI systems for materials discovery in clean energy and semiconductors, with
(#source_Tech.eu)By Christian Triantafillou Schade
UK banks warned over cybersecurity risks from restricted AI access
United KingdomGovernment and publicPayment and bankingNews
UK banks face cybersecurity risks due to restricted access to Anthropic’s AI model Mythos, a government-appointed adviser warns. The issue highlights the need for Britain to develop domestic AI capabilities and reduce reliance on US technology, Reuters reports. (REUTERS)
UK banks face cybersecurity risks amid restricted access to
(#source_Cyprus-Mail)By Christian Triantafillou Schade
Bank of England gains powers to regulate Amazon and Google
United KingdomNews
The Bank of England will regulate critical technology firms including Amazon and Google from next week to mitigate risks to financial stability and consumer protection. The move addresses vulnerabilities linked to reliance on non-EU tech providers, aligning with broader digital sovereignty concerns in Europe. (THE GUARDIAN)
Bank of England
(#source_The-Guardian)By Christian Triantafillou Schade
UK faces £1bn cloud outage risk from US provider dependence
United KingdomNews
A report warns that over 60% of UK firms—80% of FTSE 100 companies—rely on a handful of US cloud regions, with a single outage potentially costing the economy over £1 billion in 24 hours. The findings highlight systemic digital sovereignty risks amid calls for diversification. (THEREGISTER)
Britain'
By Christian Triantafillou Schade
Europe turns away from Palantir
Military and securityNetherlandsUnited KingdomSwitzerlandGermanyDenmarkNews
European governments are reducing reliance on US defence tech contractor Palantir over security and ethical concerns. The Netherlands demands a European alternative within two years, the UK plans to end NHS contracts by 2027, and Switzerland has rejected Palantir bids at least nine times. Germany and Denmark are also seeking